-
1
-
-
60549113797
-
Drugs used to treat Parkinson's disease, present status and future directions
-
Abdel-Salam O.M. Drugs used to treat Parkinson's disease, present status and future directions. CNS Neurol. Disord. Drug Targets 7 (2008) 321-342
-
(2008)
CNS Neurol. Disord. Drug Targets
, vol.7
, pp. 321-342
-
-
Abdel-Salam, O.M.1
-
2
-
-
34948869744
-
Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells
-
Anantharam V., Kaul S., Song C., Kanthasamy A., and Kanthasamy A.G. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology 2007 28 (2007) 988-997
-
(2007)
Neurotoxicology
, vol.2007
, Issue.28
, pp. 988-997
-
-
Anantharam, V.1
Kaul, S.2
Song, C.3
Kanthasamy, A.4
Kanthasamy, A.G.5
-
3
-
-
37748999265
-
Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction
-
Aoyama K., Matsumura N., Watabe M., and Nakaki T. Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction. Eur. J. Neurosci. 27 (2008) 20-30
-
(2008)
Eur. J. Neurosci.
, vol.27
, pp. 20-30
-
-
Aoyama, K.1
Matsumura, N.2
Watabe, M.3
Nakaki, T.4
-
4
-
-
68649108355
-
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
-
Banerjee R. Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim. Biophys. Acta 1792 7 (2009) 651-663
-
(2009)
Biochim. Biophys. Acta
, vol.1792
, Issue.7
, pp. 651-663
-
-
Banerjee, R.1
-
5
-
-
9244251118
-
Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings
-
Braungart E., Gerlach M., Riederer P., Baumeister R., and Hoener M.C. Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings. Neurodegener. Dis. 1 (2004) 175-183
-
(2004)
Neurodegener. Dis.
, vol.1
, pp. 175-183
-
-
Braungart, E.1
Gerlach, M.2
Riederer, P.3
Baumeister, R.4
Hoener, M.C.5
-
6
-
-
0032951125
-
-
Cassarino, D.S., 1999. The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta. 6;1453(1):49-62.
-
Cassarino, D.S., 1999. The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta. 6;1453(1):49-62.
-
-
-
-
7
-
-
69349088394
-
A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro
-
Chen W.L., Qian Y., Meng W.F., Pang J.Y., Lin Y.C., Guan Y.Y., Chen S.P., Liu J., Pei Z., and Wang G.L. A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. Biochem. Pharmacol. 78 (2009) 941-950
-
(2009)
Biochem. Pharmacol.
, vol.78
, pp. 941-950
-
-
Chen, W.L.1
Qian, Y.2
Meng, W.F.3
Pang, J.Y.4
Lin, Y.C.5
Guan, Y.Y.6
Chen, S.P.7
Liu, J.8
Pei, Z.9
Wang, G.L.10
-
8
-
-
0021800714
-
Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes
-
Chiba K., Trevor A.J., and Castagnoli N.J. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. Biochem. Biophys. Res. Commun. 128 (1985) 1228-1232
-
(1985)
Biochem. Biophys. Res. Commun.
, vol.128
, pp. 1228-1232
-
-
Chiba, K.1
Trevor, A.J.2
Castagnoli, N.J.3
-
9
-
-
0141741347
-
Parkinson's disease: mechanisms and models
-
Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
10
-
-
0023653496
-
Increased efflux rather than oxidation is the mechanism of glutathione depletion by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)
-
Di Monte D., Sandy M.S., and Smith M.T. Increased efflux rather than oxidation is the mechanism of glutathione depletion by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Biochem. Biophys. Res. Commun. 148 (1987) 153-160
-
(1987)
Biochem. Biophys. Res. Commun.
, vol.148
, pp. 153-160
-
-
Di Monte, D.1
Sandy, M.S.2
Smith, M.T.3
-
11
-
-
0037561232
-
Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease
-
Ebadi M., and Sharma S.K. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid. Redox Signal. 5 3 (2003) 319-335
-
(2003)
Antioxid. Redox Signal.
, vol.5
, Issue.3
, pp. 319-335
-
-
Ebadi, M.1
Sharma, S.K.2
-
12
-
-
55849122639
-
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
-
Henchcliffe C., and Beal M.F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. 4 (2008) 600-609
-
(2008)
Nat. Clin. Pract. Neurol.
, vol.4
, pp. 600-609
-
-
Henchcliffe, C.1
Beal, M.F.2
-
13
-
-
0034714346
-
Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease
-
Jha N., Jurma O., Lalli G., Liu Y., Pettus E.H., Greenamyre J.T., Liu R.M., Forman H.J., and Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J. Biol. Chem. 275 (2000) 26096-26101
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 26096-26101
-
-
Jha, N.1
Jurma, O.2
Lalli, G.3
Liu, Y.4
Pettus, E.H.5
Greenamyre, J.T.6
Liu, R.M.7
Forman, H.J.8
Andersen, J.K.9
-
14
-
-
0020680904
-
Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
-
Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
-
(1983)
Science
, vol.219
, pp. 979-980
-
-
Langston, J.W.1
Ballard, P.2
Tetrud, J.W.3
Irwin, I.4
-
15
-
-
33847332061
-
Modulation of 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells by K(ATP) channel block
-
Lee C.S. Modulation of 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells by K(ATP) channel block. J. Neural Transm. 114 (2007) 297-305
-
(2007)
J. Neural Transm.
, vol.114
, pp. 297-305
-
-
Lee, C.S.1
-
16
-
-
0035975702
-
Transgenic invertebrate models of age-associated neurodegenerative diseases
-
Link C.D. Transgenic invertebrate models of age-associated neurodegenerative diseases. Mech. Ageing Dev. 122 (2001) 1639-1649
-
(2001)
Mech. Ageing Dev.
, vol.122
, pp. 1639-1649
-
-
Link, C.D.1
-
17
-
-
0034624017
-
The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity
-
Lotharius J., and O'Malley K.L. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J. Biol. Chem. 275 (2000) 38581-38588
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 38581-38588
-
-
Lotharius, J.1
O'Malley, K.L.2
-
18
-
-
34250624810
-
A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases
-
Mandemakers W., Morais V.A., and De Strooper B. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. J. Cell Sci. 120 (2007) 1707-1716
-
(2007)
J. Cell Sci.
, vol.120
, pp. 1707-1716
-
-
Mandemakers, W.1
Morais, V.A.2
De Strooper, B.3
-
19
-
-
0023692602
-
Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies
-
Marongiu M.E., Piccardi M.P., Bernardi F., Corsini G.U., and Del Zompo M. Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies. Neurosci. Lett. 94 (1988) 349-354
-
(1988)
Neurosci. Lett.
, vol.94
, pp. 349-354
-
-
Marongiu, M.E.1
Piccardi, M.P.2
Bernardi, F.3
Corsini, G.U.4
Del Zompo, M.5
-
20
-
-
70349681975
-
Glutathione-a review on its role and significance in Parkinson's disease
-
Martin H.L., and Teismann P. Glutathione-a review on its role and significance in Parkinson's disease. FASEB J. 2009 23 (2009) 3263-3272
-
(2009)
FASEB J.
, vol.2009
, Issue.23
, pp. 3263-3272
-
-
Martin, H.L.1
Teismann, P.2
-
21
-
-
0036715414
-
Apoptotic molecules and MPTP-induced cell death
-
Nicotra A., and Parvez S. Apoptotic molecules and MPTP-induced cell death. Neurotoxicol. Teratol. 24 (2002) 599-605
-
(2002)
Neurotoxicol. Teratol.
, vol.24
, pp. 599-605
-
-
Nicotra, A.1
Parvez, S.2
-
22
-
-
0037916307
-
The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration
-
Nass R., and Blakely R.D. The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 521-544
-
(2003)
Annu. Rev. Pharmacol. Toxicol.
, vol.43
, pp. 521-544
-
-
Nass, R.1
Blakely, R.D.2
-
24
-
-
0031574346
-
Lithium increases melanin-concentrating hormone mRNA stability and inhibits tyrosine hydroxylase gene expression in PC12 cells
-
Presse F., Cardona B., Borsu L., and Nahon J.L. Lithium increases melanin-concentrating hormone mRNA stability and inhibits tyrosine hydroxylase gene expression in PC12 cells. Brain Res. Mol. Brain Res. 52 (1997) 270-283
-
(1997)
Brain Res. Mol. Brain Res.
, vol.52
, pp. 270-283
-
-
Presse, F.1
Cardona, B.2
Borsu, L.3
Nahon, J.L.4
-
25
-
-
51049120267
-
Dopamine neuron degeneration induced by MPP+ is independent of CED-4 pathway in Caenorhabditis elegans
-
Pu P., and Le W. Dopamine neuron degeneration induced by MPP+ is independent of CED-4 pathway in Caenorhabditis elegans. Cell Res. 18 (2008) 978-981
-
(2008)
Cell Res.
, vol.18
, pp. 978-981
-
-
Pu, P.1
Le, W.2
-
26
-
-
0025254401
-
Mitochondrial complex I deficiency in Parkinson's disease
-
Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54 (1990) 823-827
-
(1990)
J. Neurochem.
, vol.54
, pp. 823-827
-
-
Schapira, A.H.1
Cooper, J.M.2
Dexter, D.3
Clark, J.B.4
Jenner, P.5
Marsden, C.D.6
-
27
-
-
0031684326
-
Mitochondria in the etiology and pathogenesis of Parkinson's disease
-
Schapira A.H., Gu M., Taanman J.W., Tabrizi S.J., Seaton T., Cleeter M., and Cooper J.M. Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann. Neurol. 44 (1998) S89-S98
-
(1998)
Ann. Neurol.
, vol.44
-
-
Schapira, A.H.1
Gu, M.2
Taanman, J.W.3
Tabrizi, S.J.4
Seaton, T.5
Cleeter, M.6
Cooper, J.M.7
-
28
-
-
0036771852
-
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
-
Parkinson Study Group
-
Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., Juncos J.L., Nutt J., Shoulson I., Carter J., Kompoliti K., Perlmutter J.S., Reich S., Stern M., Watts R.L., Kurlan R., Molho E., Harrison M., Lew M., and Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59 (2002) 1541-1550
-
(2002)
Arch. Neurol.
, vol.59
, pp. 1541-1550
-
-
Shults, C.W.1
Oakes, D.2
Kieburtz, K.3
Beal, M.F.4
Haas, R.5
Plumb, S.6
Juncos, J.L.7
Nutt, J.8
Shoulson, I.9
Carter, J.10
Kompoliti, K.11
Perlmutter, J.S.12
Reich, S.13
Stern, M.14
Watts, R.L.15
Kurlan, R.16
Molho, E.17
Harrison, M.18
Lew, M.19
-
29
-
-
7944227203
-
Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration
-
Storch A., Ludolph A.C., and Schwarz J. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J. Neural Transm. 111 (2004) 1267-1286
-
(2004)
J. Neural Transm.
, vol.111
, pp. 1267-1286
-
-
Storch, A.1
Ludolph, A.C.2
Schwarz, J.3
-
30
-
-
84996123497
-
MPTP-induced parkinsonism as a model for Parkinson's disease
-
Tetrud J.W., and Langston J.W. MPTP-induced parkinsonism as a model for Parkinson's disease. Acta Neurol. Scand. Suppl. 126 (1989) 35-40
-
(1989)
Acta Neurol. Scand. Suppl.
, vol.126
, pp. 35-40
-
-
Tetrud, J.W.1
Langston, J.W.2
-
31
-
-
0032820452
-
Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader
-
Wang H., and Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27 (1999) 612-616
-
(1999)
Free Radic. Biol. Med.
, vol.27
, pp. 612-616
-
-
Wang, H.1
Joseph, J.A.2
-
32
-
-
33846018435
-
A functional transsulfuration pathway in the brain links to glutathione homeostasis
-
Vitvitsky V. A functional transsulfuration pathway in the brain links to glutathione homeostasis. J. Biol. Chem. 281 (2006) 35785-35793
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 35785-35793
-
-
Vitvitsky, V.1
-
33
-
-
33947517977
-
Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease
-
Yamamoto N. Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. J. Biol. Chem. 282 (2007) 4364-4372
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 4364-4372
-
-
Yamamoto, N.1
-
34
-
-
0034733970
-
Cocaine inhibits NGF-induced PC12 cells differentiation through D(1)-type dopamine receptors
-
Zachor D.A., Moore J.F., Brezausek C., Theibert A., and Percy A.K. Cocaine inhibits NGF-induced PC12 cells differentiation through D(1)-type dopamine receptors. Brain Res. 869 (2000) 85-97
-
(2000)
Brain Res.
, vol.869
, pp. 85-97
-
-
Zachor, D.A.1
Moore, J.F.2
Brezausek, C.3
Theibert, A.4
Percy, A.K.5
-
35
-
-
33846418007
-
Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease
-
Zeevalk G.D. Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease. Exp. Neurol. 203 (2007) 512-520
-
(2007)
Exp. Neurol.
, vol.203
, pp. 512-520
-
-
Zeevalk, G.D.1
-
36
-
-
71849114477
-
Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage
-
Zhao J., Li L., Ling C., Li J., Pang J.Y., Lin Y.C., Liu J., Huang R., Wang G.L., Pei Z., and Zeng J. Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage. Brain Res. 1302 (2009) 240-247
-
(2009)
Brain Res.
, vol.1302
, pp. 240-247
-
-
Zhao, J.1
Li, L.2
Ling, C.3
Li, J.4
Pang, J.Y.5
Lin, Y.C.6
Liu, J.7
Huang, R.8
Wang, G.L.9
Pei, Z.10
Zeng, J.11
|